Clinical Trial

Lithium Versus Lamotrigine in Bipolar Disorder, Type II

Study acronym: LiLa-Bipolar
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-12-14; most recent amendment 2026-03-17.
Status change: Not Yet Recruiting → Recruiting 2024-06-06
Trial Details
NCT Number NCT06184581
Lead Sponsor University Hospital Bispebjerg and Frederiksberg
Conditions Bipolar II Disorder
Enrollment 200 participants
Start Date 2024-05-08
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-20